Literature DB >> 21964675

Paget's disease of the vulva: a clinicopathologic institutional review.

Alberto A Mendivil1, Lisa Abaid, Howard D Epstein, Mark A Rettenmaier, John V Brown, John P Micha, Marie A Wabe, Bram H Goldstein.   

Abstract

BACKGROUND: The aim of this study was to assess the clinicopathologic characteristics of patients with Paget's disease of the vulva who were treated by our gynecologic oncology service between 1985 and 2010.
METHODS: Vulvar Paget's disease patient demographics, pathologic diagnosis, treatment and follow-up data were reviewed over a 25-year period.
RESULTS: The vulvar Paget's disease patients were primarily (62.5%) treated with a partial simple vulvectomy. Three patients had a history of malignancy, although none of them was intercurrent. Eleven patients had microscopically positive margins, 5 of whom developed progressive disease. Conversely, 5 patients had negative margins, of whom 4 had recurrent disease. There was a significant relationship between the presence of invasive disease and patient progression-free interval (PFI) (p = 0.007), but margin status and lesion size did not correlate with PFI (p > 0.05). Median patient PFI and follow-up was 30 and 53 months, respectively.
CONCLUSIONS: We found a significant relationship between the presence of invasive disease and patient PFI in vulvar Paget's disease although the presence of microscopic positive margins and lesion size were not prognostic indicators. In patients with high risk factors, prolonged surveillance should be considered an essential component of optimal patient management.

Entities:  

Mesh:

Year:  2011        PMID: 21964675     DOI: 10.1007/s10147-011-0325-0

Source DB:  PubMed          Journal:  Int J Clin Oncol        ISSN: 1341-9625            Impact factor:   3.402


  23 in total

Review 1.  The management of Paget's disease of the vulva.

Authors:  A B MacLean; M Makwana; Patricia E Ellis; Francina Cunnington
Journal:  J Obstet Gynaecol       Date:  2004-02       Impact factor: 1.246

2.  Cytologic detection of recurrence in extramammary Paget's disease of the vulva: a report of two cases.

Authors:  Yaku Tanaka; Toshinori Kirihara; Hajime Kitamura; Manabu Kuriyama; Hiromasa Hori; Itsuo Gorai
Journal:  Acta Cytol       Date:  2010 Sep-Oct       Impact factor: 2.319

3.  Paget's disease of the vulva treated by combined surgery and laser.

Authors:  T L Ewing
Journal:  Gynecol Oncol       Date:  1991-11       Impact factor: 5.482

4.  Paget's disease of the vulva: clinicopathologic study of type 1 cases treated at a single institution.

Authors:  H Niikura; H Yoshida; K Ito; T Takano; H Watanabe; S Aiba; N Yaegashi
Journal:  Int J Gynecol Cancer       Date:  2006 May-Jun       Impact factor: 3.437

5.  Prognostic factors in Paget's disease of the vulva: a study of 21 cases.

Authors:  D Crawford; M Nimmo; P B Clement; T Thomson; J L Benedet; D Miller; C B Gilks
Journal:  Int J Gynecol Pathol       Date:  1999-10       Impact factor: 2.762

6.  The outcomes of patients with positive margins after excision for intraepithelial Paget's disease of the vulva.

Authors:  Destin Black; Carmen Tornos; Robert A Soslow; Christopher S Awtrey; Richard R Barakat; Dennis S Chi
Journal:  Gynecol Oncol       Date:  2006-10-24       Impact factor: 5.482

7.  Clinicopathologic analysis of extramammary Paget's disease.

Authors:  C W Lee; M J Song; S H Lee; J H Kim; S J Lee; K H Lee; J S Park; S Y Hur
Journal:  Eur J Gynaecol Oncol       Date:  2011       Impact factor: 0.196

8.  Extramammary Paget's disease: prognosis and relationship to internal malignancy.

Authors:  J J Chanda
Journal:  J Am Acad Dermatol       Date:  1985-12       Impact factor: 11.527

9.  Extramammary Paget's disease of the vulva.

Authors:  D A Fishman; S K Chambers; P E Schwartz; E I Kohorn; J T Chambers
Journal:  Gynecol Oncol       Date:  1995-02       Impact factor: 5.482

10.  Paget's disease of the vulva. A ten-year experience.

Authors:  K Bakalianou; N Salakos; C Iavazzo; G Paltoglou; K Papadias; O Gregoriou; A Kondi-Pafiti
Journal:  Eur J Gynaecol Oncol       Date:  2008       Impact factor: 0.196

View more
  5 in total

Review 1.  Surgical Treatment for Extramammary Paget's Disease.

Authors:  Uwe Wollina; Alberto Goldman; Andrzej Bieneck; Mohamed Badawy Abdel-Naser; Sven Petersen
Journal:  Curr Treat Options Oncol       Date:  2018-05-03

Review 2.  Management of secondary Paget's disease of the vulva associated with transitional cell carcinoma.

Authors:  S Kajtezovic; Allison R Walker; B Hjalmarsson; S G Bell; E Everett; C Wong
Journal:  J Cancer Res Clin Oncol       Date:  2022-04-17       Impact factor: 4.553

3.  The European Society of Gynaecological Oncology (ESGO), the International Society for the Study of Vulvovaginal Disease (ISSVD), the European College for the Study of Vulval Disease (ECSVD) and the European Federation for Colposcopy (EFC) Consensus Statements on Pre-invasive Vulvar Lesions.

Authors:  Mario Preti; Elmar Joura; Pedro Vieira-Baptista; Marc Van Beurden; Federica Bevilacqua; Maaike C G Bleeker; Jacob Bornstein; Xavier Carcopino; Cyrus Chargari; Margaret E Cruickshank; Bilal Emre Erzeneoglu; Niccolò Gallio; Debra Heller; Vesna Kesic; Olaf Reich; Colleen K Stockdale; Bilal Esat Temiz; Linn Woelber; François Planchamp; Jana Zodzika; Denis Querleu; Murat Gultekin
Journal:  J Low Genit Tract Dis       Date:  2022-06-21       Impact factor: 3.842

4.  Paget's disease of the vulva: A review of 89 cases.

Authors:  Cherry O Onaiwu; Mila Pontremoli Salcedo; Suzana A Pessini; Mark F Munsell; Elizabeth E Euscher; Kellie E Reed; Kathleen M Schmeler
Journal:  Gynecol Oncol Rep       Date:  2016-12-30

5.  The Paget Trial: A Multicenter, Observational Cohort Intervention Study for the Clinical Efficacy, Safety, and Immunological Response of Topical 5% Imiquimod Cream for Vulvar Paget Disease.

Authors:  Michelle van der Linden; Kim Meeuwis; Colette van Hees; Eleonora van Dorst; Johan Bulten; Tjalling Bosse; Joanna IntHout; Dorry Boll; Brigitte Slangen; Manon van Seters; Marc van Beurden; Mariëtte van Poelgeest; Joanne de Hullu
Journal:  JMIR Res Protoc       Date:  2017-09-06
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.